Efficacy and safety profile of olaparib for patients with metastatic castration-resistant prostate cancer: A preliminary report of real-world data in a single institution in Japan.

Yasuda, Yosuke; Sakurai, Masato; Numao, Noboru; Yamamoto, Shinya; Yonese, Junji; Yuasa, Takeshi

Yasuda, Yosuke; Sakurai, Masato; Numao, Noboru; Yamamoto, Shinya; Yonese, Junji; Yuasa, Takeshi.

Afiliación

Yasuda Y; Department of Urology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
Sakurai M; Department of Urology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
Numao N; Department of Urology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
Yamamoto S; Department of Urology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
Yonese J; Department of Urology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
Yuasa T; Department of Urology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.

Int J Urol ; 30(11): 1060-1062, 2023 11.

Article en En | MEDLINE | ID: mdl-37493076

Asunto(s)

Neoplasias de la Próstata Resistentes a la Castración; Masculino; Humanos; Neoplasias de la Próstata Resistentes a la Castración/tratamiento farmacológico; Neoplasias de la Próstata Resistentes a la Castración/patología; Japón; Ftalazinas/efectos adversos; Piperazinas/efectos adversos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Próstata Resistentes a la Castración Límite: Humans / Male País/Región como asunto: Asia Idioma: En Revista: Int J Urol Asunto de la revista: UROLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Japón

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google